INVA FY 2021 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$392M+16.4% YoY

Gross Profit

$392M100.0% margin

Operating Income

$375M95.7% margin

Net Income

$266M67.8% margin

EPS (Diluted)

$2.87

Cash Flow

Operating Cash Flow

$364M

Free Cash Flow

$363M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$926M

Total Liabilities

$400M

Stockholders' Equity

$415M

Cash & Equivalents

$202M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$392M	$337M	+16.4%
Gross Profit	$392M	$337M	+16.4%
Operating Income	$375M	$321M	+16.8%
Net Income	$266M	$224M	+18.5%